检查印度传统医学的利用和临床影响
Adwaith Gopan1, Binu Kumar Bhuvanachandren Nair Jagadakumari2, Priyesh Chandrachoodan Nair1
1Department of Economics, Government College Attingal, University of Kerala, Thiruvananthapuram, Kerala, India.
Journal of public health research
|December 9, 2025
概括
人们对阿尤什 (Ayurveda,Yoga & Naturopathy,Unani,Siddha,和顺势疗法) 的认识很高,但对其药物安全性的理解很低. 这导致慢性病的无监督使用,突出需要更好地与传统医学的整合.
科学领域:
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
- 传统医学的传统医学.
背景情况:
- 政府的举措增加了印度城市AyUSH (Ayurveda,Yoga和自然疗法,Unani,Siddha和顺势疗法) 的使用.
- 之前的研究表明,AYUSH的采用率较低,因此需要进一步调查当前的使用模式.
研究的目的:
- 探索与印度Ayush使用相关的因素.
- 为了确定越来越多地采用Ayush服务背后的原因.
主要方法:
- 使用了从NSSO的Ayush调查中获得的大量二次数据集 (621,230名受访者) 的横截面研究设计.
- 采用GEE后勤回归和千平方测试来分析影响Ayush利用的因素.
主要成果:
- 对阿什的认识显示了最大的效果大小 (OR=24.17).
- 高等教育,印度教,落后种姓,消费增加和城市居住显著与更大的Ayush使用有关.
- 使用Ayush的关键原因包括治疗慢性疾病,感知安全性,负担能力和文化因素.
结论:
- 尽管人们意识到这一点,但对Ayush药物的安全性缺乏了解导致慢性疾病的无监督使用.
- 建议将AYUSH与全方位医学相结合,以改善患者的治疗结果并最大限度地降低风险.
- 虽然政府推广在城市地区是成功的,但私人机构的潜在价格上需要监控.
相关概念视频
Bioequivalence of Drugs: Drugs with Multiple Indications
141
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
141
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Therapeutic Drug Monitoring: Overview and Classification
275
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
275
Therapeutic Index
6.4K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.4K
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
MALDI-TOF Mass Spectrometry
6.4K
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...
6.4K


